Delivery Order SPE2DR25D3201-SPE2DR26FT5BY
- Not listed
- The Defense Logistics Agency awarded a $5,597.56 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract will be completed by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $11,104.04 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 4, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with the DLA. This award is issued...
- The Defense Logistics Agency awarded a $19,657.60 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with a completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $28,150.37 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 ml vials. This competitively awarded, firm fixed-price contract was issued on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. No set-aside designation was...
- The Defense Logistics Agency (DLA) awarded a $17,966.19 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Actemra 80 mg/4 mL vials, with a ceiling value of $1,924.58 and an ultimate completion date of December 16, 2025. This non-set-aside, firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $8,243.54 delivery order to AmerisourceBergen Drug Corp for 4,569,930,973 units of Actemra 400 mg/20 ml vials. This is a non-set-aside, competitively awarded firm fixed-price delivery order with a completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6.8K delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Actemra 400 mg/20 ml vials. This competitive, firm fixed-price contract is set to conclude on December 22, 2025, with performance taking place at the vendor's headquarters in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a $3,574.52 delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Actemra 400 mg/20 mL vials. The contract is non-set-aside and utilizes firm fixed-price pricing, with an ultimate completion date of December 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Actemra 400 mg/20 mL vials with a ceiling value of $16,140.74. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and maintains an ultimate completion date of October 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5BYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on January 5, 2026, with a ceiling value of $6,832.40 and ultimate completion date of January 6, 2026. This non-set-aside contract employs firm fixed pricing and represents a competitive award under AmerisourceBergen's broader relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, the company's headquarters location, where AmerisourceBergen maintains operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract supports critical medical supply chains serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating AmerisourceBergen's role as a key strategic vendor for government pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/4/26 |